1. Home
  2. PIM vs ACHV Comparison

PIM vs ACHV Comparison

Compare PIM & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PIM
    SELLHOLDBUYas of 8 hours ago
  • ACHV
    SELLHOLDBUYas of 8 hours ago
  • Stock Information
  • Founded
  • PIM 1988
  • ACHV N/A
  • Country
  • PIM United States
  • ACHV Canada
  • Employees
  • PIM N/A
  • ACHV N/A
  • Industry
  • PIM Finance Companies
  • ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
  • Sector
  • PIM Finance
  • ACHV Health Care
  • Exchange
  • PIM Nasdaq
  • ACHV Nasdaq
  • Market Cap
  • PIM 158.0M
  • ACHV 126.9M
  • IPO Year
  • PIM N/A
  • ACHV N/A
  • Fundamental
  • Price
  • PIM $3.28
  • ACHV $2.85
  • Analyst Decision
  • PIM
  • ACHV Strong Buy
  • Analyst Count
  • PIM 0
  • ACHV 5
  • Target Price
  • PIM N/A
  • ACHV $14.80
  • AVG Volume (30 Days)
  • PIM 57.5K
  • ACHV 283.6K
  • Earning Date
  • PIM 01-01-0001
  • ACHV 11-07-2024
  • Dividend Yield
  • PIM 8.28%
  • ACHV N/A
  • EPS Growth
  • PIM N/A
  • ACHV N/A
  • EPS
  • PIM 0.05
  • ACHV N/A
  • Revenue
  • PIM N/A
  • ACHV N/A
  • Revenue This Year
  • PIM N/A
  • ACHV N/A
  • Revenue Next Year
  • PIM N/A
  • ACHV N/A
  • P/E Ratio
  • PIM $63.80
  • ACHV N/A
  • Revenue Growth
  • PIM N/A
  • ACHV N/A
  • 52 Week Low
  • PIM $2.90
  • ACHV $2.87
  • 52 Week High
  • PIM $3.28
  • ACHV $5.59
  • Technical
  • Relative Strength Index (RSI)
  • PIM 52.34
  • ACHV 25.46
  • Support Level
  • PIM $3.21
  • ACHV $3.12
  • Resistance Level
  • PIM $3.30
  • ACHV $3.86
  • Average True Range (ATR)
  • PIM 0.04
  • ACHV 0.22
  • MACD
  • PIM 0.00
  • ACHV -0.04
  • Stochastic Oscillator
  • PIM 81.25
  • ACHV 0.98

Stock Price Comparison Chart: PIM vs ACHV

PIM
ACHV
AprilJulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober20250246810121416PIM VS ACHV

About PIM Putnam Master Intermediate Income Trust

Putnam Master Intermediate Income Trust is a closed-end fund. Its investment objective is to provide high current income and relative stability of net asset value. The fund pursues its goal by investing in U.S. high-grade, high-yield, and international fixed-income securities with limited maturities. The fund's portfolio includes the United States Government and agency mortgage obligations; mortgage-backed securities; corporate bonds and notes, and foreign government and agency bonds and notes.

About ACHV Achieve Life Sciences Inc.

Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use